Lista de obras -

A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy

article

A method to compare prospective and historical cohorts to evaluate drug effects. Application to the analysis of early treatment effectiveness of intramuscular interferon-β1a in multiple sclerosis patients

artículo científico publicado en 2020

APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis

artículo científico publicado en 2009

Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta

artículo científico

Are there protective treatments for cognitive decline in MS?

artículo científico publicado en 2006

Association of Neocortical Volume Changes With Cognitive Deterioration in Relapsing-Remitting Multiple Sclerosis

artículo científico publicado en 2007

Benign multiple sclerosis

artículo científico publicado en 2006

Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis

artículo científico publicado en 2006

Changes in neuropsychological test performance over the workday in multiple sclerosis.

artículo científico publicado en 2003

Cognitive changes in multiple sclerosis

artículo científico publicado en 2008

Cognitive dysfunction in multiple sclerosis: current approaches to clinical management

artículo científico publicado en 2002

Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes

artículo científico publicado en 2009

Cognitive rehabilitation in children and adolescents with multiple sclerosis

artículo científico publicado en 2010

Coping strategies, psychological variables and their relationship with quality of life in multiple sclerosis.

artículo científico publicado en 2009

Cortical functional reorganization and its relationship with brain structural damage in patients with benign multiple sclerosis

artículo científico publicado en 2010

Early prediction of the long term evolution of multiple sclerosis: the Bayesian Risk Estimate for Multiple Sclerosis (BREMS) score.

artículo científico publicado en 2007

Effects of 2-year treatment with dimethyl fumarate on cognition and functional impairment in patients with relapsing remitting multiple sclerosis

scientific article published on 01 May 2020

Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS.

artículo científico publicado en 2009

Immunomodulatory therapies delay disease progression in multiple sclerosis

artículo científico publicado en 2012

Impact of cognitive impairment on coping strategies in multiple sclerosis

artículo científico publicado en 2009

Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis

artículo científico publicado en 2004

Intravenous mitoxantrone and cyclophosphamide as second-line therapy in multiple sclerosis: an open-label comparative study of efficacy and safety

artículo científico publicado en 2008

Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies.

artículo científico publicado en 2006

Natalizumab is associated with early improvement of working ability in relapsing-remitting multiple sclerosis patients: WANT observational study results

artículo científico publicado en 2020

Neocortical volume decrease in relapsing-remitting multiple sclerosis with mild cognitive impairment

artículo científico publicado en 2006

Neopterin production and tryptophan degradation during 24-months therapy with interferon beta-1a in multiple sclerosis patients ⬇️

artículo científico publicado en 2011

New natural history of interferon-β-treated relapsing multiple sclerosis

artículo científico publicado en 2007

Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study ⬇️

artículo científico publicado el 20 de agosto de 2010

Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery

artículo científico publicado en 2010

The glycopeptide CSF114(Glc) detects serum antibodies in multiple sclerosis

scientific article published on 01 October 2005

Lista de obras de

A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy

A method to compare prospective and historical cohorts to evaluate drug effects. Application to the analysis of early treatment effectiveness of intramuscular interferon-β1a in multiple sclerosis patients

APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis

Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta

Are there protective treatments for cognitive decline in MS?

Association of Neocortical Volume Changes With Cognitive Deterioration in Relapsing-Remitting Multiple Sclerosis

Benign multiple sclerosis

Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis

Changes in neuropsychological test performance over the workday in multiple sclerosis.

Cognitive changes in multiple sclerosis

Cognitive dysfunction in multiple sclerosis: current approaches to clinical management

Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes

Cognitive rehabilitation in children and adolescents with multiple sclerosis

Coping strategies, psychological variables and their relationship with quality of life in multiple sclerosis.

Cortical functional reorganization and its relationship with brain structural damage in patients with benign multiple sclerosis

Early prediction of the long term evolution of multiple sclerosis: the Bayesian Risk Estimate for Multiple Sclerosis (BREMS) score.

Effects of 2-year treatment with dimethyl fumarate on cognition and functional impairment in patients with relapsing remitting multiple sclerosis

Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS.

Immunomodulatory therapies delay disease progression in multiple sclerosis

Impact of cognitive impairment on coping strategies in multiple sclerosis

Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis

Intravenous mitoxantrone and cyclophosphamide as second-line therapy in multiple sclerosis: an open-label comparative study of efficacy and safety

Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies.

Natalizumab is associated with early improvement of working ability in relapsing-remitting multiple sclerosis patients: WANT observational study results

Neocortical volume decrease in relapsing-remitting multiple sclerosis with mild cognitive impairment

Neopterin production and tryptophan degradation during 24-months therapy with interferon beta-1a in multiple sclerosis patients ⬇️

New natural history of interferon-β-treated relapsing multiple sclerosis

Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study ⬇️

Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery

The glycopeptide CSF114(Glc) detects serum antibodies in multiple sclerosis